United States · FDA National Drug Code directory
Dapsone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64980-566_e1aaf1ed-de8a-4c31-85de-68d728c95e86
- Product NDC
- 64980-566
- Form
- TABLET
- Composition / generic term
- dapsone
- Labeler
- Rising Pharma Holdings, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221211
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPSONE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (64980-566-01) · 64980-566-01
- 30 TABLET in 1 BOTTLE (64980-566-03) · 64980-566-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →